TARGETING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA IN PERITONEAL DIALYSIS PATIENTS - WILL IT REDUCE INFLAMMATION, ATHEROSCLEROSIS, CALCIFICATION AND IMPROVE SURVIVAL OF PERITONEAL DIALYSIS PATIENTS?: